Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies.
Rössler J, Baselga E, Davila V, Celis V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM, Kapp FG. Rössler J, et al. Among authors: celis v. Pediatr Blood Cancer. 2021 Aug;68(8):e28936. doi: 10.1002/pbc.28936. Epub 2021 Feb 13. Pediatr Blood Cancer. 2021. PMID: 33580918
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network.
Holm A, Te Loo M, Schultze Kool L, Salminen P, Celis V, Baselga E, Duignan S, Dvorakova V, Irvine AD, Boon LM, Vikkula M, Ghaffarpour N, Niemeyer CM, Rössler J, Kapp FG. Holm A, et al. Among authors: celis v. Front Pediatr. 2021 Sep 30;9:697960. doi: 10.3389/fped.2021.697960. eCollection 2021. Front Pediatr. 2021. PMID: 34660476 Free PMC article.
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.
Kobialka P, Sabata H, Vilalta O, Gouveia L, Angulo-Urarte A, Muixí L, Zanoncello J, Muñoz-Aznar O, Olaciregui NG, Fanlo L, Esteve-Codina A, Lavarino C, Javierre BM, Celis V, Rovira C, López-Fernández S, Baselga E, Mora J, Castillo SD, Graupera M. Kobialka P, et al. Among authors: celis v. EMBO Mol Med. 2022 Jul 7;14(7):e15619. doi: 10.15252/emmm.202115619. Epub 2022 Jun 13. EMBO Mol Med. 2022. PMID: 35695059 Free PMC article.
Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells.
Deyà-Martínez A, Esteve-Solé A, Vélez-Tirado N, Celis V, Costa J, Cols M, Jou C, Vlagea A, Plaza-Martin AM, Juan M, Alsina L. Deyà-Martínez A, et al. Among authors: celis v. Pediatr Allergy Immunol. 2018 Jun;29(4):425-432. doi: 10.1111/pai.12890. Epub 2018 Apr 17. Pediatr Allergy Immunol. 2018. PMID: 29532571
Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
Castillo-Ecija H, Pascual-Pasto G, Perez-Jaume S, Resa-Pares C, Vila-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farres M, Muñoz-Aznar O, Salvador N, Cuadrado-Vilanova M, Olaciregui NG, Balaguer-Lluna L, Burgueño V, Vicario FJ, Manzanares A, Castañeda A, Santa-Maria V, Cruz O, Celis V, Morales La Madrid A, Garraus M, Gorostegui M, Vancells M, Carrasco R, Krauel L, Torner F, Suñol M, Lavarino C, Mora J, Carcaboso AM. Castillo-Ecija H, et al. Among authors: celis v. J Pathol Clin Res. 2021 Jul;7(4):338-349. doi: 10.1002/cjp2.210. Epub 2021 Apr 9. J Pathol Clin Res. 2021. PMID: 33837665 Free PMC article.
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.
Mato S, Castrejón-de-Anta N, Colmenero A, Carità L, Salmerón-Villalobos J, Ramis-Zaldivar JE, Nadeu F, Garcia N, Wang L, Verdú-Amorós J, Andrés M, Conde N, Celis V, Ortega MJ, Galera A, Astigarraga I, Perez-Alonso V, Quiroga E, Jiang A, Scott DW, Campo E, Balagué O, Salaverria I. Mato S, et al. Among authors: celis v. Blood Cancer J. 2024 Oct 7;14(1):171. doi: 10.1038/s41408-024-01153-0. Blood Cancer J. 2024. PMID: 39375391 Free PMC article.
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
Ramis-Zaldivar JE, Gonzalez-Farré B, Balagué O, Celis V, Nadeu F, Salmerón-Villalobos J, Andrés M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Suñol M, Bárcena C, Garcia-Bragado F, Andión M, Azorín D, Astigarraga I, Sagaseta de Ilurdoz M, Sábado C, Gallego S, Verdú-Amorós J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Páez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, López-Guillermo A, Galera P, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, Campo E, Salaverria I. Ramis-Zaldivar JE, et al. Among authors: celis v. Blood. 2020 Jan 23;135(4):274-286. doi: 10.1182/blood.2019002699. Blood. 2020. PMID: 31738823 Free PMC article.
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J, Ramis-Zaldivar JE, Balagué O, Verdú-Amorós J, Celis V, Sábado C, Garrido M, Mato S, Uriz J, Ortega MJ, Gutierrez-Camino A, Sinnett D, Illarregi U, Carron M, Regueiro A, Galera A, Gonzalez-Farré B, Campo E, Garcia N, Colomer D, Astigarraga I, Andrés M, Llavador M, Martin-Guerrero I, Salaverria I. Salmerón-Villalobos J, et al. Among authors: celis v. Pediatr Blood Cancer. 2022 Nov;69(11):e29926. doi: 10.1002/pbc.29926. Epub 2022 Aug 24. Pediatr Blood Cancer. 2022. PMID: 36000950 Free article.
32 results